A cost effectiveness study of integrated care in health services delivery: A diabetes program in Australia

BMC Health Services Research

Volumn 8, Issue , 2008, Pages

  McRae, Ian S ^a   Butler, James R G ^a   Sibthorpe, Beverly M ^a,b   Ruscoe, Warwick ^c   Snow, Jill ^c   Rubiano, Dhigna ^a   Gardner, Karen L ^a  

^a AUSTRALIAN NATIONAL UNIVERSITY   (Australia)

^b MENZIES SCHOOL OF HEALTH RESEARCH   (Australia)

^c Southern Highlands Division of General Practice   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; ORAL ANTIDIABETIC AGENT; GLYCOSYLATED HEMOGLOBIN;

ADULT; ARTICLE; AUSTRALIA; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DATA BASE; GENERAL PRACTICE; GENERAL PRACTITIONER; HEALTH CARE DELIVERY; HEALTH PROGRAM; HEALTH SERVICE; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MEDICAL INFORMATION; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; PHARMACEUTICAL CARE; PRACTICE GUIDELINE; QUALITY ADJUSTED LIFE YEAR; AGED; CASE MANAGEMENT; COST BENEFIT ANALYSIS; DIABETES MELLITUS; DISEASE MANAGEMENT; ECONOMICS; EMPIRICAL RESEARCH; EVALUATION; FEMALE; HEALTH CARE COST; HEALTH CARE QUALITY; INTEGRATED HEALTH CARE SYSTEM; MALE; MIDDLE AGED; NONBIOLOGICAL MODEL; ORGANIZATION AND MANAGEMENT; STATISTICAL MODEL; STATISTICS;

AGED; CASE MANAGEMENT; COST-BENEFIT ANALYSIS; DELIVERY OF HEALTH CARE, INTEGRATED; DIABETES MELLITUS; DISEASE MANAGEMENT; EMPIRICAL RESEARCH; FAMILY PRACTICE; FEMALE; HEALTH CARE COSTS; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED; MODELS, ECONOMETRIC; MODELS, ORGANIZATIONAL; NEW SOUTH WALES; OUTCOME ASSESSMENT (HEALTH CARE); PROGRAM EVALUATION; QUALITY-ADJUSTED LIFE YEARS;

EID: 55349143181     PISSN: None     EISSN: 14726963     Source Type: Journal    
DOI: 10.1186/1472-6963-8-205     Document Type: Article

References (42)

1. A pragmatic cluster randomised controlled trial of a Diabetes REcall And Management system: the DREAM trial. MP Eccles P Whitty C Speed I Steen A Valoni G Hawthorne JM Grimshaw L Wood D McDowell, Implement Sci 2007 2 6 17306017 10.1186/1748-5908-2-6
2. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). United Kingdom Prospective Diabetes Study (UKPDS) Group, Lancet 1998 352 9131 837 853 10.1016/S0140-6736(05)61359-1 9742976
3. Diabetes Australia, The Royal Australian College of General Practitioners, Diabetes Management in General Practice Tuggerah, NSW: Diabetes Australia 2004
4. Physician processes and patient outcome measures for diabetes care: Relationships to organizational characteristics. MM Ward JW Yankey TE Vaughan BJ BootsMiller SD Flach S Watrin BN Doebbeling, Medical Care 2004 42 840 850 10.1097/01.mlr.0000135809.92048.d9 15319609
5. Interventions to improve the management of diabetes mellitus in primary care, outpatient and community settings. CM Renders GD Valk S Griffin EH Wagner JTM van Eijk WJJ Assendelft, Cochrane Database Syst Rev 2000 1 CD001481
6. The Cost Effectiveness of Improving Diabetes Care in U.S. Federally Qualified Community Health Centres. E Huang Q Zhang S Brown M Drum D Meltzer M Chin, Health Services Research 2007 42 2174 2193 17995559 10.1111/j.1475-6773. 2007.00734.x
7. Cost-Effectiveness of Diabetes Case Management of Low-Income Populations. T Gilmer S Roze W Valentine K Emy-Albrecht J Ray D Cobden L Nicklasson A Philis-Tsimikas A Palmler, Health Services Research 2007 42 1943 1959 10.1111/j.1475-6773.2007.00701.x 17850527
8. Lifetime health effects and costs of diabetes treatment. LW Niessen R Dijkstra R Hutubessy GEHM Rutten AF Casparie, Annals of Internal Medicine 2005 143 251 264 16103469
9. Patient-centred and professional directed implementation strategies for diabetes guidelines: a cluster-randomised trial-based cost-effectiveness analysis. R Dijkstra LW Niessen J Braspenning E Adang R Grol, Diabetic Medicine 2005 23 164 170 10.1111/j.1464-5491.2005.01751.x
10. Implementing intensive control of blood glucose concentration and blood pressure in type 2 diabetes in England: cost analysis (UKPDS 63). A Gray PM Clarke AJ Farmer RR Holman, British Medical Journal 2002 325 860 865 12386035 10.1136/bmj.325.7369.860
11. Cost Effectiveness of Prevention and Treatment of the Diabetic Foot. MM Ortegon WK Redekop LW Niessen, Diabetes Care 2004 27 901 907 10.2337/diacare.27.4.901 15047646
12. Diabetes nephropathy in the Netherlands: a cost effectiveness analysis of national clinical guidelines. N van Os LW Niessen HJG Bilo AF Casparie BA van Hout, Health Policy 2000 51 135 147 10.1016/S0168-8510(00)00063-4 10720684
13. Clinical Outcomes and Cost Effectiveness of Strategies for Managing People at High Risk for Diabetes. DM Eddy L Schlessinger R Kahn, Annals of Internal Medicine 2005 143 251 264 16103469
14. Effectiveness and efficiency of guideline dissemination and implementation strategies. JM Grimshaw RE Thomas G MacLennan C Fraser CR Ramsay L Vale P Whitty MP Eccles L Matowe L Shirran, Health Technology Assessment 2004 8 6 14960256
15. Economic evaluation of multi-disciplinary systematic care of patients with diabetes mellitus in general practice. JC Beilby C Holton J Moss M Harris J Burns G Powell-Davies, Adelaide: Primary Health Care Research and Information Service (PHCRIS) 2001
16. Cost impact of improved primary level diabetes care in remote Australian Indigenous communities. R McDermott L Segal, Australian Journal of Primary Health 2006 12 2 124 130
17. Cost-effectiveness of the primary prevention of non-insulin dependent diabetes mellitus. L Segal AC Dalton J Richardson, Health Promotion International 1998 13 197 209 10.1093/heapro/13.3.197
18. Intensive Lifestyle Changes of Metformin in Patients with Impaired Glucose Tolerance: Modeling the Long-Term Health Economic Implicatins of the Diabetes Prevention Program in Australia, Germany, Switzerland, and the United Kingdom. A Palmer S Roze W Valentine G Spinas J Shaw P Zimmet, Clinical Therapeutics 2003 26 304 321 10.1016/S0149-2918(04)90029-X
19. Recent changes in Australian general practice. M Bollen, Medical Journal of Australia 1996 164 212 215 8604189
20. Making a difference. Report of the 2005-06 Annual Survey of Divisions of General Practice. SH Hordacre C Moretti E Kalucey, Adelaide and Canberra: Primary Health Care Research and Information Service, Department of General Practice, Flinders University and Australian Government Department of Health and Ageing 2007 17760919
21. The Value of the Divisions Network. A Scott B Coote, Melbourne: Melbourne Institute of Applied Economic and Social Research, The University of Melbourne 2006
22. ®™ database system to promote quality of care in Australian general practice. JR Burns MA Bonney G Powell-Davies MF Harris, Health Informatics Journal 2004 10 177 184 10.1177/1460458204045415
23. Census of Population and Housing: Socio-Economic Indexes for Areas, Cat no. 2039.0. Australian Bureau of Statistics, Canberra: Australian Bureau of Statistics 2003
24. Population Health Health Profile of the Southern Highlands Division of General Practice: Population Profile Series No 32. Public Health Information Unit (PHIDU), Adelaide: PHIDU 2006
25. Cost-utility analysis of intensive blood glucose and tight blood pressure control in type 2 diabetes (UKPDS 72). PM Clarke A Gray A Briggs R Stevens D Matthews RR Holman, Diabetologia 2005 48 868 877 10.1007/s00125-005-1717-3 15834550
26. UKPDS Outcomes Model User Manual. University of Oxford Diabetes Trial Unit (DTU), Health Economics Research Centre (HERC), London: ISIS Innovations Ltd 2005
27. A model to estimate the lifetime health outcomes of patients with Type 2 diabetes: United Kingdom Prospective Diabetes Study (UKPDS) Outcomes Model. P Clarke A Gray A Briggs A Farmer P Fenn R Stevens D Matthews I Stratton R Holman, Diabetologia 2004 47 1747 1759 10.1007/s00125-004-1527-z 15517152
28. The CORE Diabetes Model: Projecting Long-term Clinical Outcomes, Costs and Cost-effectiveness of Interventions in Diabetes Mellitus (types 1 and 2) to Support Clinical and Reimbursement Decision-making. A Palmer S Roze W Valentine M Minshall V Foos F Lurati M Lammert G Spinas, Current Medical Research and Opinions 2004 20 S5 S26 10.1185/030079904X1980
29. 1995 Guidelines for the Pharmaceutical Industry on Preparation of Submissions to the Pharmaceutical Benefits Advisory Committee (PBAC): including major submissions involving economic analysis. Australian Government Department of Health and Ageing, Canberra: PBAC 2000
30. Funding for new medical technologies and procedures: application and assessment guidelines. Medical Services Advisory Committee, Canberra: Medical Services Advisory Committee 2005
31. Estimating utility values for health states of type 2 diabetes patients using EQ-5D (UKPDS 62). PM Clarke A Gray RR Holman, Medical Decision Making 2002 22 340 349 10.1177/027298902400448902 12150599
32. 2004-05 National Health Survey: Summary of Results Cat No 4364.0. Australian Bureau of Statistics, Canberra: Australian Bureau of Statistics 2006
33. Data extracted from tables at. Medicare Australia, 2006 https://www.medicareaustralia.gov.au/statistics/div_gen_prac.shtml
34. Costs of Diabetes in Australia, 2000-01. Bulletin No 26, AIHW Cat No AUS 59. Australian Institute of Health and Welfare (AIHW), Canberra 2005
35. Tables created from form at. Medicare Australia, http://www. medicareaustralia.gov.au/statistics/imd/forms/gpStatistics.shtml
36. Cost effectiveness analysis and the consistency of decision making: evidence from pharmaceutical reimbursement in Australia (1991-1996). G George A Harris A Mitchell, PharmacoEconomics 2001 19 1103 1109 10.2165/00019053- 200119110-00004 11735677
37. Use of Cost Effectiveness Analysis in Health-Care Resource Allocation Decision Making: How are Cost Effectiveness Thresholds Expected to Emerge? HG Eichler SZ Zong WC Gerth P Mavros B Jonsson, Value in Health 2004 7 518 528 10.1111/j.1524-4733.2004.75003.x 15367247
38. Definition, Interpretation and Calculation of Cost-Effectiveness Acceptability Curves. M Lothgren N Zethraeus, Health Economics 2000 9 623 630 10.1002/1099-1050(200010)9:7<623::AID-HEC539>3.0.CO;2-V 11103928
39. Register-recall systems: tools for chronic disease management in general practice. A Georgiou J Burns D Penn F Infante M Harris, Health Information Management 2004 33 31 35
40. Diabetes: Australian Facts 2008. Australian Institute of Health and Welfare (AIHW), Canberra: Australian Institute of Health and Welfare 2008
41. Data extracted from tables at. Medicare Australia, https://www. medicareaustralia.gov.au/statistics/div_gen_prac.shtml
42. Tables created from form at. Medicare Australia, http://www. medicareaustralia.gov.au/statistics/imd/forms/gpStatistics.shtml